Company intelligence / Profile preview

Myomedix

Neckargemünd, Baden-Württemberg, Germanymyomedix.com ↗

Ownership: Private
Development stage: Other

Overview

Myomedix is a German life science company focused on research reagents for muscle biology and myofibrillar protein studies. The company sells specialty polyclonal antibodies and recombinant proteins targeting sarcomeric and muscle-associated proteins such as titin, nebulin, MuRF1, MuRF2, RBM20, and related markers. Its products appear to be used in academic and translational research applications rather than therapeutic drug development. Based on the available public information, Myomedix operates as a niche commercial supplier of muscle-research reagents with expertise in highly specific antigens relevant to cardiac and skeletal muscle biology.

Modalities: AntibodyBiologicRecombinant proteinProtein
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Myomedix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myomedix.

Explore the full profile